Skip to main content
eScholarship
Open Access Publications from the University of California

Reduced arrhythmia inducibility with calcium/ calmodulin-dependent protein kinase II inhibition in heart failure rabbits

  • Author(s): Hoeker, GS
  • Hanafy, MA
  • Oster, RA
  • Bers, DM
  • Pogwizd, SM
  • et al.
Abstract

Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. Rationale: Calcium/calmodulin-dependent protein kinase II (CaMKII) is activated in heart failure (HF) and can contribute to arrhythmias induced by b-Adrenergic receptor-mediated sarcoplasmic reticulum calcium leak. Objective: To evaluate the effect of CaMKII inhibition on ventricular tachycardia (VT) induction in conscious HF and naive rabbits. Methods and Results: Nonischemic HF was induced by aortic insufficiency and constriction. Electrocardiograms were recorded in rabbits pretreated with vehicle (saline) or the CaMKII inhibitor KN-93 (300 mg/kg); VT was induced by infusion of increasing doses of norepinephrine (1.56-25 mgkg21min21) in naive (n = 8) and HF (n = 7) rabbits. With saline, median VT dose threshold in HF was 6.25 versus 12.5 mgkg21min21 norepinephrine in naive rabbits (P = 0.06). Pretreatment with KN-93 significantly increased VT threshold in HF and naive rabbits (median = 25 mgkg21min21, P , 0.05 vs. saline for both groups). Mean cycle length of VT initiation was shorter in HF (221 6 20 milliseconds) than naive (296 6 23 milliseconds, P , 0.05) rabbits with saline; this difference was not significant after treatment with KN-93. Conclusions: KN-93 significantly reduced arrhythmia inducibility and slowed initiation of VT, suggesting that CaMKII inhibition may have antiarrhythmic effects in the failing human heart.

Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.

Item not freely available? Link broken?
Report a problem accessing this item